Evaluation of NK1 Antagonist in Post-Traumatic Stress
ID Number 04-0900
Principal Investigator(s)Dan V. Iosifescu
Department(s) or Division(s)
Psychiatry
Description
The purpose of this study is to test the safety and effectiveness of an experimental drug for PTSD, GSK561679, compared to a placebo, which is a pill with no active substance. Patients may qualify for participation in this study if they have a diagnosis of PTSD, and have current symptoms of the disorder.
Contact Information
Solara Calderon
(212) 241-7910
solara.calderon@mssm.edu
Recruiting Patients: Yes